Baby Safety / Compounds / alpha-Farnesene

Is alpha-Farnesene safe for babies and kids?

Low risk for kids

(Babies-specific data is limited; this page draws from human adult context.) alpha-Farnesene poses low risk to adults under normal use conditions.

What is alpha-farnesene?

Also known as: Farnesene, (E,E)-alpha-farnesene, 1,3,6,10-Dodecatetraene, 3,7,11-trimethyl-, (3E,6E)-, trans,trans-alpha-farnesene.

CAS number
502-61-4
Molecular formula
C15H24
Molecular weight
204.35 g/mol
SMILES
CC(=CCCC(=CCC=C(C)C=C)C)C
PubChem CID
5281516

Risk for babies

Low risk

alpha-Farnesene poses low risk to adults under normal use conditions.

Regulatory consensus

2 regulatory and scientific bodies have classified alpha-Farnesene. The classifications differ — that's the data.

AgencyYearClassificationNotes
IFRA——Approved for use in fragrance compounds
EU——Complies with EU cosmetics regulations

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where kids encounter alpha-farnesene

  • Perfume
  • Personal Care

Safer alternatives

Lower-risk approaches that achieve a similar outcome to alpha-Farnesene:

  • Essential oil-free fragrance formulations
    Trade-offs: Allows scent without specific natural allergens; synthetic molecules can be individually safety-tested; some synthetics have their own sensitization profiles; cost comparable to natural blends.
    Relative cost: Lower (ingredient elimination)
  • Naturally-derived isolates with established safety profiles (e.g., linalool, limonene at controlled concentrations)
    Trade-offs: Removes 95-99% of dissolved contaminants including metals, PFAS, nitrates; wastes 2-4 gallons per gallon produced (improving with newer systems); removes beneficial minerals; $0.05-0.25/gallon; requires pre-treatment for longevity.
    Relative cost: 2-5× conventional
  • Fragrance-free product alternatives
    Trade-offs: Eliminates allergen risk entirely; consumer acceptance varies (some associate scent with cleanliness/efficacy); growing market segment; regulatory advantage in EU (no IFRA compliance needed).
    Relative cost: Lower (ingredient elimination)
  • Encapsulated fragrance technologies (reduced skin contact)
    Trade-offs: Reduces dermal contact by 60-90% via polymer shell release mechanism; higher formulation cost; may alter scent perception (delayed release); shell material itself requires safety assessment.
    Relative cost: 1.2-2×

Frequently asked questions

No FAQ entries generated.

See alpha-Farnesene in the baby app

Look up products containing alpha-farnesene, compare to alternatives, and explore the full data record.

Open in baby View raw API data

Sources (1)
  1. ATSDR Toxicological Profile — CAS 502-61-4 — reference

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →